In general, two main mechanisms accelerate prostate (PC) progression to CRPC: (I) activation of the androgen receptor (AR) signaling pathway, and AR variant appearance; (ii) PC cells use their own enzymatic systems to synthesize androgen hormone. The gene discussed is AR; the disease is pachyonychia congenita.